Dose-dependent renoprotection efficacy of sglt2 inhibitors in type 2 diabetes: systematic review and network meta-analysis
ConclusionThe renoprotective efficacy of SGLT2i is independent of the incremental doses suggesting lower doses may suffice for renal outcomes.
Source: Acta Diabetologica - Category: Endocrinology Source Type: research
More News: Canagliflozin | Dapagliflozin | Databases & Libraries | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Empagliflozin | Endocrinology | Forxiga | Invokana | Jardiance | Men | Science | SGLT2 Inhibitors | Sodium | Statistics | Study